References
- Mishra OP. Urinary CD 80 in nephrotic syndrome: a biomarker to distinguish minimal change disease from other glomerular diseases. Kidney Int Rep. 2020;5(11):1851–1852.
- Burrowes JD, Kovesdy CP, Byham-Gray LD, eds. Nutrition in kidney disease. 3rd ed, Switzerland: Humana Press; 2020:48,457–465.
- Sies H. Oxidative stress concept and some practical aspects. Antioxidants. 2020;9(9):852.
- Reddy VP, Zhu X, Perry G, et al. Oxidative stress in diabetes and alzheimer’s disease. J Alzheimers Dis. 2009;16(4):763–774.
- Daenen K, Andries A, Mekahli D, et al. Oxidative stress in chronic kidney disease. Pediatr Nephrol. 2019;34(6):975–991.
- Haghdoost S, Czene S, Näslund I, et al. Extracellular 8-oxo-dG as a sensitive parameter for oxidative stress in vivo and in vitro. Free Radic Res. 2005;39(2):153–162.
- Cadet J, Loft S, Olinski R, et al. Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radic Res. 2012;46(4):367–381.
- Marrocco I, Altieri F, Peluso I. Measurement and clinical significance of biomarkers of oxidative stress in humans. Oxid Med Cell Longev. 2017;2017:6501046.
- Cadet J, Berger M, Douki T, et al. Oxidative damage to DNA: formation, measurement, and biological significance. Rev Physiol Biochem Pharmacol. 1997;131:1–87.
- Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22(3):377–388.
- Kong Q, Lin CL. Oxidative damage to RNA: mechanisms, consequences, and diseases. Cell Mol Life Sci. 2010;67(11):1817–1829.
- Liguori I, Russo G, Curcio F, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018;13:757–772.
- Gan W, Nie B, Shi F, et al. Age-dependent increases in the oxidative damage of DNA, RNA, and their metabolites in normal and senescence-accelerated mice analyzed by LC-MS/MS: urinary 8-oxoguanosine as a novel biomarker of aging. Free Radic Biol Med. 2012;52(9):1700–1707.
- Nie B, Gan W, Shi F, et al. Age-dependent accumulation of 8-oxoguanine in the DNA and RNA in various rat tissues. Oxid Med Cell Longev. 2013;2013:303181.
- Shi F, Nie B, Gan W, et al. Oxidative damage of DNA, RNA and their metabolites in leukocytes, plasma and urine of Macaca mulatta: 8-oxoguanosine in urine is a useful marker for aging. Free Radic Res. 2012;46(9):1093–1098.
- Su H, Wan C, Song A, et al. Oxidative stress and renal fibrosis: mechanisms and therapies. Adv Exp Med Biol. 2019;1165:585–604.
- Baines RJ, Chana RS, Hall M, et al. CD36 mediates proximal tubular binding and uptake of albumin and is upregulated in proteinuric nephropathies. Am J Physiol Renal Physiol. 2012;303(7):F1006–1014.
- Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, et al. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 2018;9(2):119.
- Sitar ME, Aydin S, Cakatay U. Human serum albumin and its relation with oxidative stress. Clin Lab. 2013;59(9-10):945–952.
- Wang W-X, Luo S-B, Xia M-M, et al. Analysis of the oxidative damage of DNA, RNA, and their metabolites induced by hyperglycemia and related nephropathy in sprague dawley rats. Free Radical Res. 2015;49(10):1199–1209.
- Mao Y-H, Xu L-N, Weng Q-H, et al. The ratio of plasma and urinary could be a novel evaluation index for patients with chronic kidney disease. Oxid Med Cell Longev. 2018;2018:4237812.
- Shih YM, Cooke MS, Pan CH, et al. Clinical relevance of guanine-derived urinary biomarkers of oxidative stress, determined by LC-MS/MS. Redox Biol. 2019;20:556–565. 10.1016/j.redox.2018.11.016.
- Gerstein HC, Mann JF, Yi Q, HOPE Study Investigators, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421–426.
- Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ. 2008;336(7654):1185–1189.
- Yang GF, Schoepf UJ, Zhu H, et al. Thromboembolic complications in nephrotic syndrome: imaging spectrum.[J]. Acta Radiol. 2012;53(10):1186–1194.
- Wen YK. Necrotizing fasciitis caused by Serratia marcescens: a fatal complication of nephrotic syndrome. Ren Fail. 2012;34(5):649–652.
- Cameron JS. The nephrotic syndrome and its complications. Am J Kidney Dis. 1987;10(3):157–171.
- Cardoso BA, Leal R, Sá H, et al. Acute liver failure due to primary amyloidosis in a nephrotic syndrome: a swiftly progressive course. BMJ Case Rep. 2016;2016:bcr2016214392.
- Kaneko K, Kimata T, Takahashi M, et al. Change in urinary 8-hydroxydeoxyguanosine in idiopathic nephrotic syndrome. Pediatr Nephrol. 2012;27(1):155–156; author reply 157.
- Liang Y-D, Liu Q, Du M-H, et al. Urinary 8-oxo-7,8-dihydroguanosine as a potential biomarker of frailty for elderly patients with cardiovascular disease. Free Radic Biol Med. 2020;152:248–254.
- Gan W, Liu X-L, Yu T, et al. Urinary 8-oxo-7,8-dihydroguanosine as a potential biomarker of aging. Front Aging Neurosci. 2018;10:34.
- Brégeon D, Sarasin A. Hypothetical role of RNA damage avoidance in preventing human disease - ScienceDirect. Mutat Res. 2005;577(1-2):293–302.
- Traut TW. Physiological concentrations of purines and pyrimidines. Mol Cell Biochem. 1994;140(1):1–22.
- Arisz L, Donker AJ, Brentjens JR, et al. The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome. Acta Med Scand. 1976;199(1-2):121–125.
- Wang WX, Luo SB, Jiang P, et al. Increased oxidative damage of RNA in Early-Stage nephropathy in db/db mice[J]. Oxid Med Cell Longev. 2017;2017:2353712–2353729.
- Broedbaek K, Siersma V, Henriksen T, et al. Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patients. Diabetes Care. 2011;34(12):2594–2596.
- Kobayashi S, et al. Urinary 8-hydroxy-2'-deoxyguanosine reflects symptomatic status and severity of systolic dysfunction in patients with chronic heart failure. Eur J Heart Fail. 2014;13(1):29–36.
- Murugaiyan SB, Ramasamy R, Nakkeeran M, et al. Urinary 8-hydroxydeoxyguanosine as a marker of oxidative stress induced genetic toxicity in oral cancer patients. Indian J Dent Res. 2015;26(3):226–230.
- Poulsen HE, et al. Oxidatively generated modifications to nucleic acids in vivo: measurement in urine and plasma. Free Radical Biol Med. 2019;145.
- Mao Y-H, Weng Q-H, Xu L-N, et al. Levels of and in random urine are consistent with 24 h urine in healthy subjects and patients with renal disease. Free Radic Res. 2017;51(6):616–621. 10.1080/10715762.2017.1346249.
- Rahman T, Hosen I, Islam MMT, et al. Oxidative stress and human health. Adv Biosci Biotechnol. 2012;03(7):997–1019.
- Mannucci C, Casciaro M, Sorbara EE, et al. Nutraceuticals against oxidative stress in autoimmune disorders. Antioxidants. 2021;10(2):261.